Last Week in Event SPACE ...
Buy Immunomedics Inc (IMMU US) at 3.2% or wider. The limited conditionality attached to the Offer would indicate this may complete early. However, deals like this should trade wider than normal because of the very small chance of losing a very large amount of money in case of deal disruption of any kind.
(This insight covers specific insights & comments involving Stubs, Pairs, Arbitrage, share Classifications, and Events - or SPACE - in the past week)
NTT Docomo Inc (9437 JP) (Mkt Cap: $119bn; Liquidity: $142mn)
After the Nikkei published articles that NTT (Nippon Telegraph & Telephone) (9432 JP) would soon launch a Tender Offer to buy out the minority shareholders of its mobile telephony subsidiary and largest mobile phone operator in Japan by subscriber count NTT Docomo, NTT announced it would conduct a Tender Offer to buy out minorities at ¥3900/share, which is a 40.5% premium to the undisturbed price. Given the ownership circumstances and the trading prices of other telecom stocks out there, this is a Very High Price Indeed. Is this deal fair? Yes, for NTT Docomo Shareholders. Not for NTT Shareholders.
Links to:
Travis insights: NTT Docomo SHOCKER - Nikkei Says Parent NTT To Buy Out Docomo Minorities & NTT Deal for DoCoMo - Not Going Gentle, Definitely Raging Against the Dying of the Light
Mio Kato's insights: NTT – Initial Thoughts Reading Through the Lines of the Shock News & NTT – NTT Is Going Big and Our Suspicions Are Aroused Further.
Evergrande Real Estate Group (3333 HK) (Mkt Cap: $33.2bn; Liquidity: $47mn)
A letter purportedly submitted by Evergrande to the Guangdong government asking for assistance lest its cash-crunch lead to much worse has been disavowed, and called a fake by the company. Various news reports have said since that denial that they have seen the letter. The letter lays out the problem of repaying RMB 130bn to investors if the company is not allowed to backdoor-list Hengda Real Estate before end-January 2021.
(link to Travis' insight: Evergrande May Be Facing a Funding Squeeze)
Evergrande Auto (708 HK) (Mkt Cap: $22.6bn; Liquidity: $59mn)
In StubWorld: Evergrande Auto (708 HK) Tapping All & Sundry; ASM Pacific Going Private?, I discussed Evergrande Auto announcement of an intention to list on the "Star Market". A notice for the EGM has now been despatched. The EGM will be held on the 20 October. Pricing has yet to be determined for the listing, but the announcement states an intention to issue at not less than HK$25/share. Applying the timeline for a handful of precedent RMB issuances, Evergrande Auto's listing on the STAR board could potentially take place in late Jan/early Feb 2021.
(link to my insight: Evergrande Auto (708 HK): EGM Ahead Of Star Market Listing)
Vedanta Ltd (VEDL IN) (Mkt Cap: $6.9bn; Liquidity: $31mn)
On 29 September, Vedanta provided an announcement to the Exchanges to the effect that the BSE and NSE had provided In-Principle Approval for the Delisting Offer on 28 September 2020. As per SEBI guidelines, the announcement of that was due today. This had been previewed in an article in the Economic Times yesterday, and shares touched a recent high at INR 140.00/share before closing at a recent high of INR 139+. Once the In-Principle Approval is received, the schedule gets quite tight. The announcement of the Delisting Offer in a newspaper was provided with the announcement and that sets things off.
(link to Travis' insight: Vedanta Reverse Book Build Auction - It’s On And the Schedule From Here Is Tight)
Shimachu Co Ltd (8184 JP) (Mkt Cap US$1.5bn; Liquidity $10mm day (now)
(link to Travis' insight: DCM Does a Full Takeover of Shimachu - Looks Like a Strong Price. Look Again.)
Wilmar International (WIL SP) (Mkt Cap: $20.5bn; Liquidity: $46mn)
Back on the 12 July, Wilmar announced that the CSRC had accepted Yihai Kerry Arawana Holdings' (YKA) application for its proposed listing on the Shenzhen Stock Exchange (ChiNext Board). I discussed this IPO in Wilmar: China Ops IPO One Step Closer. An indicative timetable has now been issued with an expected listing mid-October. The issue price will be RMB25.70/share, or a 31.12x YKA's FY19 recurring net profit. Wilmar mentions the average PER of listed companies peers (agricultural and food processing companies on the ChiNext) was 41.86x over the past month. I see the one year average of 36x.
(link to my insight: Wilmar: YKA's Pricing & Cheap Rump Stake)
In Zhongdi Dairy (1492 HK): Possible MGO from Yili, I discussed the SSA between the Zhang Group and Inner Mongolia Yili Industrial Group (A) (600887 CH), such that Yili holds 43.75% in China Zhongdi Dairy (1492 HK), triggering an MGO. The MGO will be HK$1.132/share (an 11% premium to last close). The price will not be increased. The SSA is primarily subject to independent shareholder approval and China's SAMR. The MGO is subject to a 50% (of all shares out) acceptance condition. Despite the meagre headline Offer premium to last close, Zhongdi shares are up 129% YTD. Apart from timing associated with regulatory approvals, this looks a done deal.
In Toshiba – Kioxia’s Postponed IPO Is NOT About US-China Tensions and That Means More Downside Risk, Mio discusses reports that Kioxia would be postponing its much-anticipated IPO due to US-China tensions. He questions whether postponing the IPO further will lead to greater returns down the road. He feels there is downside risk for Toshiba.
In Celltrion Merger Announcement: Details, Questionable Aspects, & Trading Dynamics, Sanghyun Park discusses Celltrion's three-way merger plan.
In Lee Myung-Hee Gives Big Stakes of Emart and Shinsegae to Her Son & Daughter, Douglas Kim discusses the family change of shares in E Mart Inc (139480 KS) and Shinsegae (004170 KS).
Swire Pacific (A) (19 HK) / Swire Properties (1972 HK)
Swire Pac's discount to NAV of 50% is around its all-time low. The implied stub, stripping out its 82% holding in Swire Prop, is at its lowest level since Properties was listed in Jan 2012. At 0.2x P/B, Swire Pac is cheap. However, the expectation it will maintain its vested interest in Cathay Pacific Airways (293 HK) via taking up its rights, places a big black mark over the company.
Swire Pac pumped in HK$5.3bn for its share of Cathay's rights. It's 45% stake is now worth HK$15.8bn, down from HK$20.4bn at the beginning of the year. Before factoring in the rights take-up.
(link to my insight: StubWorld: Swire's All-Time Low Stub, But ... )
On the 13 September, Gilead Sciences (GILD US) announced it had entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00/share in cash, a 108% premium to last close, in a US$20bn deal. The tender offer is not subject to any financing condition with ~US$15bn of the funding from existing cash and ~US$6bn in newly issued debt. Conditions to the tender offer are limited - valid tendering of 50% + one share, no MACs, and the waiting period applicable to the Offer under the HSR Act having expired or been terminated.
links to:
my insight: Gilead/Immunomedics: Bosom Buddies
Shifara Samsudeen's insight: more: Gilead: Will Immunomedics Be Gilead’s Next Pharmasset?
Robert Sassoon's insight: MergerTalk: Gilead Sciences Takeover Of Immunomedics -Still Something In It For The Arbitrageurs
In Sogou/Tencent: And That's A Wrap, I discussed Sogou Inc (SOGO US) entering into a definitive agreement for a Going-Private Transaction at the same Offer price of US$9/share. Separately, Sohu.com Inc (SOHU US) has entered into a share purchase agreement with Tencent concerning its stake in Sogou, the completion of which will result in Tencent holding not less than 90% of the voting power in Sogou. Therefore the Merger will be in the form of a short-form merger as per section 233(7) of the Companies Law of the Cayman Islands - there is no vote. There are no dissenting rights. Done deal - the Merger is expected to close in the fourth quarter of 2020.
(link to Travis' insight: Rolls Royce Rights Roll Right Over You)
In Ahlstrom-Munksjo (AM1 FH): Tender Offer Trading Tight - Will There Be Bumpitrage?, Janaghan Jeyakumar discusses Ahlstrom-Munksjo (AM1 FH) agreeing to be acquired by a consortium of investors consisting of Bain Capital and current top shareholders Ahlström Capital, and Viknum AB and Belgrano Inversiones. Following the completion of the Transaction, Bain Capital is expected to indirectly own 55% while Ahlström Capital and Viknum will hold 36% and 9% respectively. The transaction is structured as a Tender Offer and the Offer Price will be EUR18.10 per share in cash (37.1% premium). Minimum Acceptance Condition requires that the Acquirer gains control of more than 90%. This requires an acceptance rate of at least ~85% (i.e. 55%/65%) from shareholders outside the irrevocable undertakings. This is quite high. A bump in terms cannot be ruled out.
KLCI Index Rebalance Preview. Based on last market prices, Brian Freitas see Supermax Corp (SUCB MK) and Kossan Rubber Industries (KRI MK) being included in the index, and expect Genting Malaysia (GENM MK) and Genting Bhd (GENT MK) to be deleted. Brian's insight: KLCI Index Rebalance Preview: Getting the Glove Makers to Fit.
NTT Docomo replacement. Brian sees Murata Manufacturing (6981 JP), Renesas Electronics (6723 JP) and Sharp Corp (6753 JP) as the most likely candidates to replace NTT Docomo Inc (9437 JP). There is a lower probability of ROHM Co Ltd (6963 JP) or Anritsu Corp (6754 JP) being included in the index. Brian's insight: Nikkei 225 Index Rebalance: Likely Candidates to Replace NTT Docomo.
YuanShengTai Dairy Farm (1431 HK) has announced that due to an inadvertent oversight by the Offeror, it was not brought to the attention of the Executive (of the SFC) before the Rule 3.5 Announcement that PRC anti-trust approval was required for the Offers and such requirement was not disclosed in the Rule 3.5 Announcement. The Offeror is now in the process of preparing the anti-trust filings. This makes sense - the China Zhongdi Dairy (1492 HK) transaction ( Zhongdi Dairy (1492 HK): Possible MGO from Yili) needs SAMR sign-off. The despatch of the Composite Document has also been pushed to the 12 October.
Pre-con Offer from Shandong Gold Mining Co., Ltd. (1787 HK) for Hengxing Gold Holding (2303 HK). Pre-cons include approvals from NDRC and MOFCOM. The Offer will be by way of a Scheme with the consideration in scrip - approximate 0.17241* SDGM H Share. Works out to a slight discount to last close. SGM has received irrevocable totaling 75% of the votes of Hengxing. So that's pretty much a lock.
My ongoing series flags large moves (~10%) in CCASS holdings over the past week or so, moves which are often outside normal market transactions. These may be indicative of share pledges. Or potential takeovers. Or simply help understand volume swings.
Often these moves can easily be explained - the placement of new shares, rights issue, movements subsequent to a takeover, lock-up expiry, amongst others. For those mentioned below, I could not find an obvious reason for the CCASS move.
Name | % chg | Into | Out of |
K Group (8475 HK) | 42.44% | Quaser | Outside CCASS |
The following large movement(s) concern recently listed companies, and therefore are (likely) lock-up related.
Name | % chg | Into | Out of |
Zai Lab (9688 HK) | 65.22% | Citi | Outside CCASS |
Baozun (9991 HK) | 1,003.18% | JPM | Outside CCASS |
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.